Study of Safety and Efficiency of the Drug Reamberin® in the Intensive Care of Patients With Acute Ethanol Intoxication
Condition(s):Ethanol IntoxicationLast Updated:February 8, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):Ethanol IntoxicationLast Updated:February 8, 2023Recruiting
Condition(s):DeliriumLast Updated:December 20, 2017Terminated
Condition(s):Critical Illness; Sarcopenia; Muscle WastingLast Updated:March 17, 2016Completed
Condition(s):SedationLast Updated:August 17, 2016Completed
Condition(s):Sleep; Patient Compliance; Intensive Care Unit Acquired WeaknessLast Updated:November 22, 2022Completed
Condition(s):Acute on Chronic Liver Failure; Variceal Hemorrhage; Cirrhosis, Liver; Thromboelastometry; Thrombosis;PortalLast Updated:May 1, 2023Recruiting
Condition(s):Neurologic DisorderLast Updated:September 24, 2012Withdrawn
Condition(s):Delirium; Critical Illness; Acute EncephalopathyLast Updated:July 27, 2023Recruiting
Condition(s):Cirrhosis; End Stage Liver Disease; Acute Kidney Injury; Liver Transplant; Complications; Chronic Kidney Diseases; Hepatitis c; Hepatitis B; NASH – Nonalcoholic Steatohepatitis; Alcoholic Cirrhosis; Hepatocellular CarcinomaLast Updated:December 27, 2023Terminated
Condition(s):Postoperative Mortality and MorbidityLast Updated:November 10, 2014Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.